- US11975043utility2024Gene Therapy for Neurodegenerative Disorders0 cites
- US11969418utility2024Therapeutic Tyrosine Kinase Inhibitors for Relapsing Multiple Sclerosis (RMS)0 cites
- US11957765utility2024Gene Therapy for Neurometabolic Disorders0 cites
- US11945874utility2024Anti-human CD52 Immunoglobulins0 cites
- US11927596utility2024Assays for Detecting the Presence or Amount of an Anti-drug Antibody0 cites
- US11920120utility2024Integrated Continuous Isolation of Fluid Streams from Sterile Process Vessels0 cites
- US11911440utility2024Gene Therapy for Neurodegenerative Disorders0 cites
- US11912739utility2024Sterile Chromatography and Manufacturing Processes0 cites
- US11912741utility2024Continuous Production of Recombinant Proteins0 cites
- US11896651utility2024Gene Editing of Deep Intronic Mutations0 cites
- US11898175utility2024Treatment of Abnormal Bone Conditions in Acid Sphingomyelinase Deficiency Patients0 cites
- US11897876utility2024Isoxazolidines as RIPK1 Inhibitors and Use Thereof0 cites
- US11884703utility2024Methods of Processing a Fluid Including a Recombinant Therapeutic Protein and Use Thereof0 cites
- US11878024utility2024Tropomyosin-related Kinase (trk) Inhibitors0 cites
- US11879004utility2024Modified Binding Polypeptides for Optimized Drug Conjugation0 cites
- US11857512utility2024Pharmaceutical Compositions Comprising Venglustat0 cites
- US11851482utility2023Anti-complement Factor Bb Antibodies and Uses Thereof0 cites
- US11839861utility2023Sterile Chromatography Resin and Use Thereof in Manufacturing Processes0 cites
- US11840710utility2023Methods for Purification of Recombinant AAV Vectors0 cites
- US11834495utility2023Modified-igg Antibodies That Bind Transforming Growth Factor-beta1 with High Affinity, Avidity and Specificity0 cites